Results 1 to 10 of about 475 (85)

Prolonged Hematogone Expansion Is Associated with Better Outcomes in Allogeneic Hematopoietic Stem Cell Transplantation Recipients [PDF]

Hematology Reports
Background/Objectives: Hematogones, B cell precursors, are considered a clock of bone marrow reconstitution after chemotherapy and hematopoietic stem cell transplantation (HSCT).
Bianca Serio, Danilo De Novellis, Marisa Gorrese, Angela Bertolini, Paola Manzo, Francesca Picone, Anna Maria Della Corte, Rossella Marcucci, Denise Morini, Michela Rizzo, Roberto Guariglia, Serena Luponio, Pasqualina Scala, Francesco Verdesca, Anna Maria Sessa, Francesca Velino, Martina De Leucio, Maddalena Langella, Valentina Giudice, Carmine Selleri   +19 more
doaj   +2 more sources

Observations on hematogones with light chain restriction. [PDF]

Leukemia Research Reports, 2022
Light-chain restricted hematogones (LCR HGs) detected by flow cytometry (FC) may, occur in bone marrow mimicking involvement by a B-cell lymphoma. This phenomenon can present a diagnostic pitfall and negatively impact patient management, and may occur in
Angela D'Ardia, Valeria Ciliberti, Pio Zeppa, Alessandro Caputo   +3 more
doaj   +2 more sources

The presence of precursors of benign pre-B lymphoblasts (hematogones) in the bone marrow of a paediatric patient with cytomegalovirus infection.

Clinical Medicine Oncology, 2008
Hematogones are normal B-lymphoid precursors that multiply in the bone marrow of small children and of adults with ferropenic anaemia, neuroblastoma or idiopathic thrombocytopenic purpura.
F Moreno-Madrid, J Uberos, M Díaz-Molina, A Ramírez-Arredondo, P Jiménez-Gámiz, A Molina-Carballo   +5 more
exaly   +2 more sources

Real-time immunophenotypic shifts in pediatric B lymphoblastic leukemia providing implications for minimal residual disease detection [PDF]

Advances in Laboratory Medicine
Disease monitoring in acute leukemia management is crucial for risk stratification and chemotherapy response assessment. Minimal residual disease (MRD) testing is the most reliable tool, measuring antigenic expression differences between leukemic cells ...
Javed Omer, Mansoor Neelum, Jabbar Naeem, Khan Hamza, Israr Talha, Maqsood Sidra, Jamal Saba, Meraj Fatima   +7 more
doaj   +2 more sources

ALL-Net: integrating CNN and explainable-AI for enhanced diagnosis and interpretation of acute lymphoblastic leukemia [PDF]

PeerJ Computer Science
This article presents a new model, ALL-Net, for the detection of acute lymphoblastic leukemia (ALL) using a custom convolutional neural network (CNN) architecture and explainable Artificial Intelligence (XAI).
Abhiram Thiriveedhi, Swetha Ghanta, Sujit Biswas, Ashok K. Pradhan   +3 more
doaj   +3 more sources

Hematogones in CD34+ leukapheresis units: Is it important to quantify and report them? [PDF]

Hematology, Transfusion and Cell Therapy
Rebeca Brasil Albuquerque, Hélio Lopes da Silva, Fernando Barroso Duarte, Daniel Mazza Matos   +3 more
doaj   +2 more sources

Pseudo-Kappa Light Chain Restricted Hematogones in Patients Receiving Daratumumab [PDF]

Turkish Journal of Hematology, 2022
Hamza Tariq, Urooj Zahra
doaj   +2 more sources

B-cell precursors (hematogones) in CD34+ hematopoietic stem cell collections: a single-center experience [PDF]

Einstein (São Paulo), 2022
Daniel Mazza Matos
doaj   +2 more sources

PB1753: EVALUATION OF IMMUNOPHENOTYPIC CHARACTERISTICS OF RESIDUAL CELLS IN COMPARISON WITH NORMAL HEMATOGONES AND MATURE CELLS IN CHILDREN WITH B-CELL LYMPHOBLASTIC LEUKEMIA [PDF]

HemaSphere, 2023
Oksana Karnabeda, Kateryna Vilchevska, Iryna Bakhchivandzhi   +2 more
doaj   +2 more sources

Bone Marrow Grafts From Pediatric Donors May Contain A Considerable Number of Hematogones [PDF]

Indian Journal of Hematology and Blood Transfusion, 2022
Namık Özbek, Özlem Arman Bilir, Melek Işık   +2 more
exaly   +2 more sources